Quick Search

 

 


 

 

Result Summary for 111344

Result Summary
Protocol ID: 111344
Clinical Study ID: 111344
Official Title: Immunogenicity and reactogenicity of GSK Bio's DTPa-HBV-IPV/hib vaccine when given as a booster dose.
Phase: phase 2
Study Indications or Diseases:
  • Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis Vaccines
Generic Name: Combined Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Poliomyelitis Vaccine
Trade/Product Name: Infanrix_hexa
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.